Akzo Nobel To Pay $36M In Third Settlement Over Remeron Patent Evergreening

Law360, New York (October 21, 2004, 12:00 AM EDT) -- Dutch drug maker Akzo Nobel has agreed to pay $36 million to settle a class-action lawsuit brought by U.S. states and public sector health purchasers over an alleged attempt to evergreen patents on the former blockbuster antidepressant Remeron.

Organon also has agreed to strong injunctive relief that will require the company to make timely listing of patents and prohibits Organon from submitting false or misleading listing information to the FDA, state attorneys general said in a statement.

The agreement follows a deal struck earlier this month...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.